Name | Number of supported studies | Average coverage | |
---|---|---|---|
extravillous trophoblast | 3 studies | 41% ± 15% |
Insufficient scRNA-seq data for expression of HSD3B1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 95% | 36.46 | 244 / 258 | 6% | 1.31 | 14 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 42.53 | 1 / 1 |
liver | 57% | 15.49 | 129 / 226 | 14% | 1.01 | 58 / 406 |
intestine | 35% | 103.37 | 341 / 966 | 18% | 0.47 | 97 / 527 |
skin | 40% | 126.72 | 727 / 1809 | 1% | 0.11 | 5 / 472 |
bladder | 5% | 0.38 | 1 / 21 | 23% | 3.60 | 117 / 504 |
prostate | 17% | 2.26 | 42 / 245 | 1% | 0.01 | 4 / 502 |
adipose | 15% | 3.31 | 177 / 1204 | 0% | 0 | 0 / 0 |
stomach | 0% | 0.08 | 1 / 359 | 12% | 0.46 | 34 / 286 |
breast | 5% | 0.65 | 25 / 459 | 2% | 0.25 | 27 / 1118 |
pancreas | 5% | 0.57 | 16 / 328 | 3% | 2.54 | 5 / 178 |
lung | 4% | 0.66 | 21 / 578 | 1% | 1.14 | 15 / 1155 |
uterus | 1% | 0.25 | 2 / 170 | 3% | 0.44 | 16 / 459 |
esophagus | 0% | 0.04 | 2 / 1445 | 4% | 0.45 | 7 / 183 |
ovary | 2% | 0.97 | 4 / 180 | 1% | 0.02 | 6 / 430 |
brain | 3% | 0.24 | 78 / 2642 | 0% | 0.00 | 1 / 705 |
kidney | 2% | 0.16 | 2 / 89 | 1% | 0.01 | 6 / 901 |
heart | 1% | 0.17 | 11 / 861 | 0% | 0 | 0 / 0 |
spleen | 1% | 0.07 | 2 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.06 | 6 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.09 | 6 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.03 | 3 / 803 | 0% | 0 | 0 / 0 |
thymus | 0% | 0.02 | 2 / 653 | 0% | 0 | 0 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0006703 | Biological process | estrogen biosynthetic process |
GO_0021766 | Biological process | hippocampus development |
GO_0006694 | Biological process | steroid biosynthetic process |
GO_0008207 | Biological process | C21-steroid hormone metabolic process |
GO_0006702 | Biological process | androgen biosynthetic process |
GO_0051412 | Biological process | response to corticosterone |
GO_0005730 | Cellular component | nucleolus |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0045171 | Cellular component | intercellular bridge |
GO_0030868 | Cellular component | smooth endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0047024 | Molecular function | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity |
GO_0003854 | Molecular function | 3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity |
GO_0004769 | Molecular function | steroid delta-isomerase activity |
GO_0000253 | Molecular function | 3-keto sterol reductase activity |
GO_0005515 | Molecular function | protein binding |
GO_0016616 | Molecular function | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
Gene name | HSD3B1 |
Protein name | 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I) (3-beta-HSD I) (3-beta-hydroxy-5-ene steroid dehydrogenase) (3-beta-hydroxy-Delta(5)-steroid dehydrogenase) (EC 1.1.1.145) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Delta-5-3-ketosteroid isomerase) (Dihydrotestosterone oxidoreductase) (EC 1.1.1.210) (Steroid Delta-isomerase) (EC 5.3.3.1) (Trophoblast antigen FDO161G) Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
Synonyms | HSDB3A 3BH |
Description | FUNCTION: A bifunctional enzyme responsible for the oxidation and isomerization of 3beta-hydroxy-Delta(5)-steroid precursors to 3-oxo-Delta(4)-steroids, an essential step in steroid hormone biosynthesis. Specifically catalyzes the conversion of pregnenolone to progesterone, 17alpha-hydroxypregnenolone to 17alpha-hydroxyprogesterone, dehydroepiandrosterone (DHEA) to 4-androstenedione, and androstenediol to testosterone. Additionally, catalyzes the interconversion between 3beta-hydroxy and 3-oxo-5alpha-androstane steroids controlling the bioavalability of the active forms. Specifically converts dihydrotestosterone to its inactive form 5alpha-androstanediol, that does not bind androgen receptor/AR. Also converts androstanedione, a precursor of testosterone and estrone, to epiandrosterone . Expected to use NAD(+) as preferred electron donor for the 3beta-hydroxy-steroid dehydrogenase activity and NADPH for the 3-ketosteroid reductase activity (Probable). . |
Accessions | ENST00000369413.8 ENST00000531340.5 P14060 ENST00000528909.1 E9PRN7 |